{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:44:21Z","timestamp":1790624661659,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010585","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000}}],"reference-count":128,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010585.pub2","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T12:51:36Z","timestamp":1519044696000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Combination pharmacotherapy for the treatment of fibromyalgia in adults"],"prefix":"10.1002","volume":"2020","author":[{"given":"Joelle","family":"Thorpe","sequence":"additional","affiliation":[{"name":"Anesthesiology & Perioperative Medicine; Queen's University; Kingston Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Shum","sequence":"additional","affiliation":[{"name":"Anesthesiology & Perioperative Medicine; Queen's University; Kingston Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gilron","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology & Perioperative Medicine & Biomedical & Molecular Sciences; Queen's University; Kingston Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD010585.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/1756-185X.12904","article-title":"Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: a randomized double-blind study","volume":"19","author":"Albertoni Giraldes","year":"2016","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett","year":"2003","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/art.21319","article-title":"Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol\/acetaminophen","volume":"4","author":"Bennett","year":"2005","journal-title":"Arthritis and Rheumatology"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-15-40","article-title":"Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial","volume":"15","author":"Zanette","year":"2014","journal-title":"BMC Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/j.pain.0000000000000558","article-title":"Combination of pregabalin with duloxetine for fibromyalgia","volume":"157","author":"Gilron","year":"2016","journal-title":"Pain"},{"issue":"11","key":"10.1002\/14651858.CD010585.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.1780291110","article-title":"A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia","volume":"29","author":"Goldenberg","year":"1986","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010585.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780391111","article-title":"A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia","volume":"39","author":"Goldenberg","year":"1996","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-079X.2010.00836.x","article-title":"Adjuvant use of melatonin for treatment of fibromyalgia","volume":"50","author":"Hussain","year":"2011","journal-title":"Journal of Pineal Research"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J094v02n01_02","article-title":"Alprazolam and ibuprofen in the treatment of fibromyalgia - report of a double-blind placebo-controlled study","volume":"2","author":"Kravitz","year":"1994","journal-title":"Journal of Musculoskeletal Pain"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-4613-0381-7_58","article-title":"Fibromyalgia and migraine, two faces of the same mechanism","volume":"398","author":"Nicolodi","year":"1996","journal-title":"Recent Advances in Tryptophan Research"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/JPR.S127288","article-title":"A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia","volume":"10","author":"Pridgen","year":"2017","journal-title":"Journal of Pain Research"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3959(95)00199-9","article-title":"Comparison of tenoxicam and bromazepam in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Quijada-Carrera","year":"1996","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD010585.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/art.1780340507","article-title":"Treatment of primary fibrositis\/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study","volume":"34","author":"Russell","year":"1991","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD010585.pub2-BIB0014|cit14","first-page":"953","article-title":"Treatment of fibromyalgia syndrome with Super Malic\u00ae: a randomized, double blind, placebo controlled, crossover pilot study","volume":"22","author":"Russell","year":"1995","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02030081","article-title":"Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp\u00ae) versus placebo","volume":"8","author":"Vaer\u00f8y","year":"1989","journal-title":"Clinical Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1533-2500.2010.00362.x","article-title":"Effect of intravenous lidocaine on manifestations of fibromyalgia","volume":"10","author":"Vlainich","year":"2010","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AJP.0b013e3181ffbfde","article-title":"Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia","volume":"27","author":"Vlainich","year":"2011","journal-title":"Clinical Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD010585.pub2-BIB0018|cit18","first-page":"2069","article-title":"Lessons learned combining N-of-1 trials to assess fibromyalgia therapies","volume":"33","author":"Zucker","year":"2006","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/acm.2008.0410","article-title":"Intravenous micronutrient therapy (Myers\u2019 Cocktail) for fibromyalgia: a placebo-controlled pilot study","volume":"15","author":"Ali","year":"2009","journal-title":"Journal of Alternative and Complementary Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00296-011-2334-8","article-title":"Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia?","volume":"33","author":"Bagis","year":"2013","journal-title":"Rheumatology International"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/art.21319","article-title":"Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol\/acetaminophen","volume":"53","author":"Bennett","year":"2005","journal-title":"Arthritis and Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-2007-972572","article-title":"Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial","volume":"40","author":"Calandre","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"95","key":"10.1002\/14651858.CD010585.pub2-BIB0023|cit23","first-page":"1","article-title":"Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study","volume":"12","author":"Calandre","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0024|cit24","first-page":"97","article-title":"Fluoxetine associated with cyclobenzaprine to treat fibromyalgia","volume":"85","author":"Cantini","year":"1994","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0025|cit25","first-page":"103","article-title":"Effectiveness of fluoxetine associated with cyclobenzaprine in the treatment of fibromyalgia: twelve-months-follow up results","volume":"85","author":"Cantini","year":"1995","journal-title":"Reumatismo"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0026|cit26","unstructured":"Choi JW Lee CJ Lee SM Shin BS Jun B Sim WS Effect of hyaluronidase addition to lidocaine for trigger point injection in myofascial pain syndrome Pain Practice 10.1111\/papr.12362"},{"issue":"119","key":"10.1002\/14651858.CD010585.pub2-BIB0027|cit27","first-page":"1","article-title":"Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study","volume":"8","author":"Cuatrecasas","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010585.pub2-BIB0028|cit28","first-page":"562","article-title":"Effect of growth hormone as add-on treatment in severe fibromyalgia syndrome. Results from the IIIB, CT27560 placebo-controlled, multicenter trial","volume":"70","author":"Cuatrecasas","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.pain.2012.02.012","article-title":"Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia","volume":"153","author":"Cuatrecasas","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jpain.2010.01.073","article-title":"Effect of adding milnacipran to pregabalin in the management of fibromyalgia: a randomized, open-label, controlled study","volume":"11","author":"Farmer","year":"2010","journal-title":"Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0031|cit31","first-page":"99","article-title":"Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome","volume":"12","author":"Fossaluzza","year":"1992","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2 Suppl 96","key":"10.1002\/14651858.CD010585.pub2-BIB0032|cit32","first-page":"S152","article-title":"Effects of a paracetamol and tramadol fixed-dose combination on pain, asthenia, cognitive disorders and sleep quality in fibromyalgia","volume":"34","author":"Ghini","year":"2016","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD010585.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.21191","article-title":"A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications","volume":"52","author":"Holman","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"14","key":"10.1002\/14651858.CD010585.pub2-BIB0034|cit34","first-page":"693","article-title":"Rheumajecta and Vasolastine treatment of primary fibromyalgia: results of a randomized, placebo-controlled, double-blind study","volume":"134","author":"Jacobs","year":"1990","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0035|cit35","first-page":"128","article-title":"Fluoxetine and amitriptyline in the treatment of fibromyalgia","volume":"44","author":"Johnson","year":"1997","journal-title":"Journal of Family Practice"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00482-010-1003-2","article-title":"Medium-term effects of a multimodal therapy on patients with fibromyalgia. Results of a controlled efficacy study","volume":"25","author":"Lange","year":"2011","journal-title":"Der Schmerz"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1749-6632.2009.04811.x","article-title":"An open-label study adding creatine monohydrate to ongoing medical regimens in patients with the fibromyalgia syndrome","volume":"1173","author":"Leader","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"10","key":"10.1002\/14651858.CD010585.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/03007998809111116","article-title":"A double-blind comparison of ibuprofen, placebo and ibuprofen with meptazinol in soft tissue rheumatism","volume":"10","author":"Le Gallez","year":"1988","journal-title":"Current Medical Research and Opinon"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/147323000203000213","article-title":"An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome","volume":"30","author":"Lister","year":"2002","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1759720X13483894","article-title":"Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin","volume":"5","author":"Mease","year":"2013","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"issue":"21","key":"10.1002\/14651858.CD010585.pub2-BIB0041|cit41","first-page":"1062","article-title":"Treatment of primary fibromyalgia using Rheumajecta and Vasolastine: results of a randomized, placebo-controlled, double-blind study","volume":"134","author":"Nollen","year":"1990","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0042|cit42","first-page":"49","article-title":"The use of botulinum toxin type A in the treatment of myofascial pain syndromes","volume":"32","author":"Porta","year":"1999","journal-title":"Riabilitazione"},{"issue":"1-2","key":"10.1002\/14651858.CD010585.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(99)00264-X","article-title":"A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm","volume":"85","author":"Porta","year":"2000","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD010585.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","article-title":"Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial","volume":"32","author":"Potvin","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0045|cit45","first-page":"S826","article-title":"A combination of celecoxib and famciclovir is efficacious in the treatment of fibromyalgia: results of a phase IIa randomized, double-blind, placebo-controlled study","volume":"66","author":"Pridgen","year":"2014","journal-title":"Arthritis and Rheumatology"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0046|cit46","first-page":"18","article-title":"Effect of treating fibromyalgia syndrome with the combination of tramadol and amitriptyline","volume":"8","author":"Qin","year":"2009","journal-title":"Chinese Journal of Rural Medicine and Pharmacy"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/papr.12409","article-title":"Comparative efficacy of newer antidepressants in combination with pregabalin for fibromyalgia syndrome: a controlled, randomized study","volume":"17","author":"Ramzy","year":"2017","journal-title":"Pain Practice"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.mehy.2009.01.052","article-title":"Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?","volume":"73","author":"Recla","year":"2009","journal-title":"Medical Hypotheses"},{"issue":"5","key":"10.1002\/14651858.CD010585.pub2-BIB0049|cit49","first-page":"S16","article-title":"An open-label study of levopromazine (methotrimeprazine) as an add-on therapy in fibromyalgia management","volume":"27","author":"Rico-Villademoros","year":"2009","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0050|cit50","first-page":"197","article-title":"Efficacy of phenylbutazone-prednisone combination in the treatment of acute lumbosacral fibrositis: a survey of 96 cases","volume":"9","author":"Settel","year":"1967","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"9","key":"10.1002\/14651858.CD010585.pub2-BIB0051|cit51","first-page":"1322","article-title":"Experimental investigation of the effect of a combination of quinine, lithium and salicylic acid by means of various methods","volume":"24","author":"Szirmai","year":"1974","journal-title":"Arzneimittelforschung"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010585.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/S0924-977X(09)70392-X","article-title":"Ropinirole as a coadjuvant treatment in the management of refractory patients with fibromyalgia: a case series","volume":"19","author":"Vilchez","year":"2009","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AJP.0b013e3181ffbfde","article-title":"Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia","volume":"27","author":"Vlainich","year":"2011","journal-title":"Clinical Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0054|cit54","first-page":"112","article-title":"The combination of the local therapy with dimethylsulfoxide and NSAIDs and acupuncture in the treatment of patients with fibromyalgia","volume":"53","author":"Zborovsky","year":"1994","journal-title":"Zeitschrift f\u00fcr Rheumatologie"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0055|cit55","first-page":"200","article-title":"Observation on therapeutic effect of herb-partitioned moxibustion on fibromyalgia syndrome","volume":"29","author":"Zhao","year":"2009","journal-title":"Zhonqquo Zhen Jiu"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0056|cit56","unstructured":"Lidocaine on manifestations of fibromyalgia (LIMAFIBRO)"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0057|cit57","unstructured":"Study to assess the clinical benefit of droxidopa and droxidopa\/carbidopa in subjects with fibromyalgia (FMS201)"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0058|cit58","unstructured":"A study of IMC-1 in patients with fibromyalgia"},{"issue":"5","key":"10.1002\/14651858.CD010585.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2012.02.010","article-title":"A framework for fibromyalgia management for primary care providers","volume":"87","author":"Arnold","year":"2012","journal-title":"Mayo Clinic Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD010585.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","article-title":"Characteristics and healthcare costs of patients with fibromyalgia syndrome","volume":"61","author":"Berger","year":"2007","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11926-012-0278-y","article-title":"Monotherapy or combination therapy for fibromyalgia treatment?","volume":"14","author":"Calandre","year":"2012","journal-title":"Current Rheumatology Reports"},{"issue":"9","key":"10.1002\/14651858.CD010585.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14656566.2015.1047343","article-title":"An update on pharmacotherapy for the treatment of fibromyalgia","volume":"16","author":"Calandre","year":"2015","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.1780260701","article-title":"Clinical characteristics of fibrositis. I. A \u201cblinded,\u201d controlled study of symptoms and tender points","volume":"26","author":"Campbell","year":"1983","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","author":"Chaparro","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"15","key":"10.1002\/14651858.CD010585.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012188.pub2","article-title":"Gabapentin for fibromyalgia pain in adults","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010585.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008244.pub3","article-title":"Milnacipran for pain in fibromyalgia in adults","author":"Cording","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mcna.2015.08.012","article-title":"Multimodal treatment of chronic pain","volume":"100","author":"Dale","year":"2016","journal-title":"Medical Clinics of North America"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD010585.pub2-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011790.pub2","article-title":"Pregabalin for pain in fibromyalgia in adults","author":"Derry","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/17512433.2016.1145052","article-title":"Novel pharmaceutical options for treating fibromyalgia","volume":"9","author":"Gerardi","year":"2016","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"19","key":"10.1002\/14651858.CD010585.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","article-title":"Management of fibromyalgia syndrome","volume":"292","author":"Goldenberg","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1521-6942(03)00042-1","article-title":"The epidemiology of chronic generalized musculoskeletal pain","volume":"17","author":"Gran","year":"2003","journal-title":"Best Practice & Research. Clinical Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1358\/dot.2011.47.7.1603503","article-title":"Available therapies and current management of fibromyalgia: focusing on pharmacologic agents","volume":"47","author":"Han","year":"2011","journal-title":"Drugs of Today"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","article-title":"Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis","volume":"301","author":"Hauser","year":"2009","journal-title":"JAMA"},{"issue":"1-2","key":"10.1002\/14651858.CD010585.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials","volume":"145","author":"Hauser","year":"2009","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejpain.2009.01.006","article-title":"Guidelines on the management of fibromyalgia syndrome - a systematic review","volume":"14","author":"Hauser","year":"2010","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009318.pub2","article-title":"Lacosamide for neuropathic pain and fibromyalgia in adults","author":"Hearn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0084|cit84","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"d5928","key":"10.1002\/14651858.CD010585.pub2-BIB0085|cit85","first-page":"1","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00393-004-0531-5","article-title":"Chronic widespread pain and tender points in low back pain: a population-based study","volume":"63","author":"H\u00fcppe","year":"2004","journal-title":"Zeitschrift f\u00fcr Rheumatologie"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"55","key":"10.1002\/14651858.CD010585.pub2-BIB0088|cit88","first-page":"1","article-title":"Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L\u2019Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.18553\/jmcp.2016.22.3.263","article-title":"Treatment patterns associated with ACR-recommended medications in the management of fibromyalgia in the United States","volume":"22","author":"Liu","year":"2016","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0092|cit92","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD010585.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11916-008-0068-4","article-title":"Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy?","volume":"12","author":"Mease","year":"2008","journal-title":"Current Pain and Headache Reports"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0095|cit95","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejpain.2011.08.009","article-title":"A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine","volume":"16","author":"Moore","year":"2012","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - \"no worse than mild pain\" as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"8","key":"10.1002\/14651858.CD010585.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011824","article-title":"Amitriptyline for fibromyalgia in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0106|cit106","first-page":"50","volume-title":"Statistics with Confidence - Confidence Intervals and Statistical Guidelines","author":"Morris","year":"1995"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0109|cit109","unstructured":"Palliative and Supportive Care Group PaPaS Author and Referee Guidance papas.cochrane.org\/papas-documents"},{"issue":"8","key":"10.1002\/14651858.CD010585.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0111|cit111","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0112|cit112","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0113|cit113","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1185\/03007990902728456","article-title":"The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis","volume":"25","author":"Silverman","year":"2009","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0115|cit115","first-page":"928","article-title":"Two contributions to understanding the \u201cfibrositis syndrome\u201d","volume":"28","author":"Smythe","year":"1977","journal-title":"Bulletin on the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010585.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0307-742X(21)00264-2","article-title":"Fibrositis as a disorder of pain modulation","volume":"5","author":"Smythe","year":"1979","journal-title":"Clinics in Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BioMed Central Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD010585.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BioMed Central Neurology"},{"issue":"10","key":"10.1002\/14651858.CD010585.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0120|cit120","first-page":"885","article-title":"The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada","volume":"26","author":"White","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD010585.pub2-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010585.pub2-BIB0122|cit122","first-page":"1159","article-title":"Fibrositis: symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals","volume":"12","author":"Wolfe","year":"1985","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010585.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.","volume":"33","author":"Wolfe","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD010585.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3899\/jrheum.081180","article-title":"Fibromyalgia wars","volume":"36","author":"Wolfe","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD010585.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.","volume":"62","author":"Wolfe","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1002\/14651858.CD010585.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"issue":"1","key":"10.1002\/14651858.CD010585.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0049-0172(81)90096-2","article-title":"Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls","volume":"11","author":"Yunus","year":"1981","journal-title":"Seminars in Arthritis and Rheumatism"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010585.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T13:54:58Z","timestamp":1685714098000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010585.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":128,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010585.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]}}}